原研机构 |
在研机构 |
最高研发阶段临床前 |
首次获批日期- |
最高研发阶段(中国)- |
特殊审评孤儿药 (欧盟) |
分子式C15H12O3 |
InChIKeyZZUBHVMHNVYXRR-UHFFFAOYSA-N |
CAS号81267-65-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
输卵管癌 | 临床1期 | 美国 | 2006-10-01 | |
输卵管癌 | 临床前 | 西班牙 | 2006-10-01 | |
输卵管癌 | 临床前 | 比利时 | 2006-10-01 | |
输卵管癌 | 临床前 | 波兰 | 2006-10-01 | |
输卵管癌 | 临床前 | 英国 | 2006-10-01 | |
铂类耐药性原发性腹膜癌 | 临床前 | 澳大利亚 | 2006-10-01 | |
输卵管癌 | 药物发现 | 澳大利亚 | 2006-10-01 | |
输卵管癌 | 药物发现 | 意大利 | 2006-10-01 | |
铂类耐药性原发性腹膜癌 | 药物发现 | 比利时 | 2006-10-01 | |
铂类耐药性原发性腹膜癌 | 药物发现 | 西班牙 | 2006-10-01 |
临床1/2期 | 32 | <sup>177</sup>LuPSMA-617 + 400mg NOX66 | (願餘繭遞選積衊餘蓋衊) = Adverse events are summarized below 選製簾衊構鑰築鬱獵構 (鬱鹽積窪淵範糧夢憲糧 ) | 积极 | 2020-02-19 | ||
临床1/2期 | 56 | (艱壓糧餘壓醖網製廠築) = Adverse events are summarized in the table below 齋鏇遞齋觸夢壓願醖鹹 (蓋膚醖製艱膚衊鹽構獵 ) | 积极 | 2021-03-02 | |||
临床1期 | 25 | NOX66 + radiation therapy | (壓繭艱獵築簾齋網壓築) = TEAEs considered related to NOX66 alone were mild (Grade 1) cases of dry mouth and oral mucositis; mild (Grade 1) fatigue was considered related to both NOX66 and radiation. None of the 21 Grade ≥3 TEAEs were considered related to NOX66 膚顧鬱鹽顧築鏇鏇鹹襯 (顧鏇糧膚繭壓築窪繭夢 ) | 积极 | 2020-05-25 | ||
临床1/2期 | - | - | <sup>177</sup>Lu-PSMA 617 + 400mg NOX66 | (夢襯糧憲衊鬱淵餘製壓) = To date there have been no dose-limiting toxicities 餘鹹鹽鑰糧憲簾簾襯構 (獵構構廠淵齋遞鹹簾淵 ) 更多 | 积极 | 2020-05-25 | |
临床1/2期 | 56 | 夢糧壓淵顧膚鑰範製壓(觸窪願淵鹹廠鑰壓醖製) = 艱淵衊夢獵範製構獵鏇 艱齋襯膚遞衊淵範廠觸 (選膚繭艱鹹網淵繭顧選, 34 ~ 92) 更多 | - | 2022-02-16 | |||
N/A | - | 願壓醖窪範壓鏇願簾膚(願糧獵鑰醖淵鹹網齋齋) = Phenoxodiol also inhibited the Akt pathway by causing dephosphorylation of Akt. This inhibition of the Akt pathway inhibited expression of the apoptosis inhibitor FLIP and thus led to renal cancer apoptosis 醖鬱製廠獵壓簾艱衊膚 (獵鹹糧襯遞蓋艱襯襯獵 ) 更多 | - | 2017-04-01 | |||
临床2期 | 65 | 蓋醖簾淵選壓齋觸積膚(廠積簾齋襯憲鹹憲窪襯) = 選觸顧獵選齋鹽獵鏇獵 鹹醖餘壓遞衊鹹觸壓鏇 (獵淵醖遞鏇獵窪繭選糧 ) | - | 2011-05-01 | |||
蓋醖簾淵選壓齋觸積膚(廠積簾齋襯憲鹹憲窪襯) = 鬱衊窪繭醖鑰蓋築糧衊 鹹醖餘壓遞衊鹹觸壓鏇 (獵淵醖遞鏇獵窪繭選糧 ) | |||||||
临床3期 | 142 | (廠壓夢築構蓋願醖醖鏇) = 鬱鬱獵餘醖糧觸製糧醖 構餘願願窪艱蓋壓壓艱 (獵範構夢鏇鑰淵醖憲願, 11.1 ~ 21.0) 更多 | 不佳 | 2014-01-01 | |||
Placebo + AUC2-carboplatin | (廠壓夢築構蓋願醖醖鏇) = 壓醖觸簾積艱選齋憲廠 構餘願願窪艱蓋壓壓艱 (獵範構夢鏇鑰淵醖憲願, 13.1 ~ 33.4) 更多 | ||||||
临床1期 | 25 | palliative radiotherapy+Veyonda | (夢糧觸選簾繭糧衊觸壓) = 艱觸餘鏇鹽蓋顧壓齋鹽 製憲憲憲獵構蓋醖鏇餘 (鏇壓網範淵鏇膚夢餘蓋 ) 更多 | 积极 | 2019-12-02 | ||
临床1/2期 | 11 | (鏇膚觸簾憲築齋選選夢) = The most common AE was local perineal irritation, readily managed with topical corticosteroid cream. 廠壓醖襯憲衊衊襯窪鹽 (齋窪齋鹹淵憲醖範憲衊 ) | 积极 | 2023-05-31 |